Alpay Ozcan1, Ozge Uygun2, Fuat Kaan Aras1, Murat Gultekin3, Zuhal Yapici2, and Alp Dincer4
1Acibadem Mehmet Ali Aydinlar Univ., Istanbul, Turkey, 2Neurology, Istanbul University, Istanbul, Turkey, 3Neurology, Erciyes University, Kayseri, Turkey, 4Radiology, Acibadem Mehmet Ali Aydinlar Univ., Istanbul, Turkey
Synopsis
QSM has the potential of describing objectively iron accumulation in brain regions such as basal ganglia which is relevant in neurodegeneration with brain iron accumulation (NBIA). Herein, for accurately assessing iron accumulation, a new metric, high susceptibility density, is introduced against mean value pitfalls which may be hindered by negative susceptibility within ROIs. When analyzing iron accumulation in basal ganglia of 16 patients with subtypes PKAN dispersion, KUFOR lower and PLAN higher accumulation, MPAN separation was obeserved in the Globus Pallidus-Red Nucleus space compared to healthy volunteers.
Introduction
Neurodegeneration with brain iron accumulation (NBIA) is a set of highly
debilitating genetic disorders with short life expectancy affecting children
and adults. MR’s role is crucial in initial diagnosis as the first suspicion is
drawn from increased iron deposition observed in clinical MRIs1. Qualitative special features, such as “eye of
the tiger”2 sign in T2W images, are in clinical use but are
insufficient especially for understanding mechanisms behind selective iron deposition
in globus pallidus and substantia nigra. In contrast, recently popularized
quantitative susceptibility mapping3 (QSM) methods might provide significant objective
information for overcoming the broad phenotypic NBIA range and variability.Methods
In
this IRB approved study, MR data were collected from 16 NBIA patients (11 with
anesthesia) 7, 2, 3, 1 male and 2, 0, 0, 1, female PKAN, PLAN, MPAN and
Kufor-Rakeb patients respectively with $$$21.37\pm 13.98\mathrm{yrs.}$$$
and range $$$[5\mathrm{yrs.}- 35\mathrm{yrs.}]\cup \{56\mathrm{yrs. (male, PKAN)}\} $$$
who were referred
from the collaborating institutions. MRIs were also collected without
anesthesia from 11 (5
females) healthy volunteers
of
$$$ 29.54 \pm 13.76\mathrm{yrs.} $$$ with $$$ [7\mathrm{yrs.} - 49\mathrm{yrs.}] $$$
range. Prior to imaging, informed written consent was obtained
from the volunteers, patients or their legal guardians.
MRI
data were collected on a Siemens™ Magnetom Prisma® 3 Tesla scanner equipped
with a 60 cm gantry, a 80 mT/m gradient with 200 T/m/s slew rate and a 64
channel head/neck coil. A 3D FLASH sequence with (single echo) TE=30ms, TR=45ms
was used for QSM data collection. Axial 256x256 images with a resolution of
0.86x0.86x2 mm/voxel were obtained.
All
images were converted from DICOM to NIfTI format MIPAV4 software which was also used for brain
surface extraction (BSE) algorithm. BSE brain masks were then fed to the QSM software
package STI Suite5-7 v2.2 along with the phase images for obtaining
susceptibility maps. Therein, phase scaling (to
$$$2\pi$$$),
phase unwrapping and background phase removal using iHARPERELLA (integrated
HARmonic (background) PhasE REmovaL using the Laplacian operator) routine7 were performed respectively prior to
applying iLSQR (improved sparse linear equation and least-squares) algorithm.
Basal
ganglia regions, CN, PT, GP, RN and SN were manually segmented independently
from QSM images using MIPAV4’s draw polygon segmentation tool on
either unprocessed phase images or frequency shift maps. region of interest (ROI)
based data analysis and presentation were realized with in-house developed
MATLAB™ 2018b (Mathworks™, Natick, MA, USA) code.
By
ferromagnetism, iron increases magnetic susceptibility of brain tissue8. However, heterogeneous iron distributions,
paramagnetic and diamagnetic tissue with negative susceptibility might impair
accumulation assessment when using ROI mean values as metric. Accordingly, for
assessing iron accumulation within ROIs more precisely than mean ROI-susceptibility
we propose herein a novel metric. First, the volume of high susceptibility ($$$\chi_t$$$
)
values above a chosen threshold
is calculated as
$$V(\chi_t)=\int\limits_{\chi(x)>\chi_t} dx=\sum_i I(\chi(x_i)>\chi_t) \quad (x,x_i \in R^3)$$
where $$$I$$$ denotes the indicator function. Subsequently, high
susceptibility density $$$\rho(\chi_t)$$$ defined as
$$\rho(\chi_t)=\frac{1}{V(\chi_t)}=\int\limits_{\chi(x)>\chi_t} dx=\frac{1}{V(\chi_t)}\sum\limits_{i, s.t. \chi(x_i)>\chi_t} \chi(x_i) \quad (x,x_i \in R^3)$$
is calculated for each patient’s ROIs. The threshold
was chosen
by inspecting the data for high iron concentration while providing best subject
clusters in ROI-scatter
plots (see figure).Results
Whereas
TH, PT and CN demonstrate cluster heterogeneity with various levels of healthy
subject clustering (not shown), GP plays a key role in separating subtypes and
healthy volunteers. RN and SN display similar properties however with a lesser
prominence.
With
the exception of one 27Y, male PKAN patients demonstrate age dependent
simultaneous increase in GP-RN (see figure), while a 5Y and 8Y fall apart from
the linear trend with low RN values. In contrast, older healthy volunteers have
higher accumulation in RN but not in GP.
Two
Kufor-Rakeb patients remain clustered in GP-RN-SN combinations with
accumulations lower, similar and higher in GP, SN and RN respectively compared
to healthy cohort (RN-SN not shown).
PLAN-28Y-M
patient have consistently a large accumulation in all ROI combinations
similarly for PKAN-56Y-M patient which is expected with age related accumulation.
MPAN patients remain
close to each other but are separated from the patients and volunteers with
values in mid-high range in GP and SN.Conclusion
The mechanisms of iron accumulation, including the discovery of new NBIA
genes and pathways is an ongoing research topic. In this preliminary study, to
the best of our knowledge QSM data collected from a rare cohort of patients
provided for the first time means of describing and differentiating basal
ganglia regions affected by NBIA subtypes. The method herein might potentially
be effective in supporting future NBIA
molecular and genetic research.Acknowledgements
Special thanks to Arzu Karabay for providing genomic information.References
1. Hayflick, S.J., Kurian, M.A. & Hogarth, P.
in Handbook of Clinical Neurology, Vol. 147. (eds. D.H. Geschwind, H.L. Paulson
& C. Klein) 293-305 (Elsevier, 2018).
2. Delgado, R.F. et al. Missense PANK2 mutation
without “Eye of the tiger” sign: MR findings in a large group of patients with
pantothenate kinase-associated neurodegeneration (PKAN). Journal of Magnetic Resonance Imaging 35, 788-794 (2012).
3. Deistung, A., Schweser, F. & Reichenbach,
J.R. Overview of quantitative susceptibility mapping. NMR in Biomedicine 30,
e3569-n/a (2017).
4. McAuliffe,
M. MIPAV (Medical Image Processing, Analysis, and Visualization). Retrieved
from https://mipav.cit.nih.gov/
5. Liu, C.
Retrieved from https://people.eecs.berkeley.edu/~chunlei.liu/software.html
6. Wu, B., Li, W., Guidon, A. & Liu, C. Whole
brain susceptibility mapping using compressed sensing. Magnetic Resonance in Medicine 67,
137-147 (2012).
7. Li, W., Avram, A.V., Wu, B., Xiao, X. &
Liu, C. Integrated Laplacian-based phase unwrapping and background phase
removal for quantitative susceptibility mapping. NMR in Biomedicine 27,
219-227 (2014).
8. Duyn, J.H. & Schenck, J. Contributions to
magnetic susceptibility of brain tissue. NMR
in Biomedicine 30, e3546-n/a
(2017).